Detecting CTE in the brains of living individuals could improve our understanding of the disease and inform research regarding prevention and treatment.
The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.
Elevated lipoprotein(a) and corresponding LPA genotypes are also associated with an increased risk for ischemic stroke, although the incremental risk is less pronounced.
The link between negative respiratory effects and air pollution is intuitive however, recent research has shown a robust association between pollution and myocardial infarction, heart failure, and stroke.
Individuals with migraine or severe headaches may be more likely to have other chronic health conditions.
A recent meta-analysis found there is insufficient evidence supporting the link between some forms of subclinical atrial fibrillation and an increased risk of thrombotic events.
In the robot-assisted training for the upper limb after stroke (RATULS) trial, researchers aimed to establish whether robot-assisted training improved upper limb function after stroke compared with enhanced upper limb therapy and usual care alone.
In patients with aneurysmal subarachnoid hemorrhage, there are insufficient data to indicate which patient-reported outcome measures are suitable for evaluating patient-reported outcomes.
Low-dose aspirin use for primary prevention of cardiovascular events in people without symptomatic cardiovascular disease was associated with an increased risk for intracranial hemorrhage.
The decline in midlife ischemic strokes over time is less pronounced than the decline among older adults.